-
Q&A
Writing Through ItIn a new book and on her New York Times blog, author Susan Gubar chronicles her experiences living with metastatic cancer.
by Marci A. Landsmann
-
In the Moment- Summer 2013
Matt Hiznay, Diane Fowler, Roxann Merino.
-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
-
When Cancer Rings Twice
One out of every six people diagnosed with cancer this year will be facing it for, at least, the second time.
by Melissa Weber
-
Yesterday & Today
The Amazing RideSally Ride's life was cut short by pancreatic cancer. But as the first American woman in space, she still inspires girls to pursue careers in science–and reach for the stars.
by Alexandra Goho
-
Changing the Face of Clinical Trials
Efforts are under way to increase African-American enrollment in cancer clinical trials.
by Leslie Harris O'Hanlon
-
Forever Young
In images of four breast cancer survivors navigating the medical system, photographer David Jay captures portraits of emotional strength, economic struggle and hope.
by Cynthia Ryan
-
In the Moment- Spring 2013
Valentina Londono, Beth Foster, Michael Knowlton, Beverly Brehl.
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
-
Survivor Profile
Let’s Talk: Lee MillerDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
Cancer Talk
Online Second Opinions
More than half of patients who participated in a program offering online second opinions were recommended a change to their treatment plan.
by Eric Fitzsimmons
Musical Toxicity an Effect of Cancer TreatmentStudy finding cancer treatment affects ability to play or sing music highlights need for physical therapy, experts say.
by Kyle Bagenstose
Treatment Lags Behind Guidelines for Many Men With Prostate CancerGuidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon